PPD to Present at Barclays Global Healthcare Conference
24 Février 2021 - 1:00PM
Business Wire
PPD, Inc. (Nasdaq: PPD), a leading global contract research
organization, will present virtually at the Barclays Global
Healthcare Conference. David Simmons, chairman and CEO, and Chris
Scully, CFO, are scheduled to participate in a fireside chat on
Tuesday, March 9, 2021, at 3:35 p.m. (U.S. Eastern Time).
The presentation can be accessed live on PPD’s investor
relations website at https://investors.ppd.com. An archived version
of the presentation will be available for up to 30 days.
About PPD
PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and
lifecycle management services. Our customers include
pharmaceutical, biotechnology, medical device, academic and
government organizations. With locations in 46 countries and more
than 26,000 professionals worldwide, PPD applies innovative
technologies, therapeutic expertise and a firm commitment to
quality to help customers bend the cost and time curve of drug
development and optimize value in delivering life-changing
therapies to improve health. For more information, visit
www.ppd.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210224005540/en/
Investors: Tracy Krumme +1 910 558 4186 investors@ppd.com
Media: media@ppd.com
Pharmaceutical Product Developme (NASDAQ:PPDI)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Pharmaceutical Product Developme (NASDAQ:PPDI)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Pharmaceutical Prod Dev (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Pharmaceutical Prod Dev (MM)